Interested parties can join the conference call by dialing 877-407-0989 for toll-free access or 201-389-0921 for international participants, ten minutes before the scheduled start. A live webcast and subsequent replay will also be accessible through the company's investor relations website at www.amphastar.com.
Amphastar focuses on the development and manufacturing of complex generic and proprietary injectable, inhalation, and intranasal products. The company’s portfolio includes notable brands such as BAQSIMI, Primatene MIST, and Cortrosyn, which are distributed primarily through group purchasing organizations and drug wholesalers.
Comments (0)
No comments yet. Be the first!